A Trial of Neurofeedback as an Adjunctive Treatment for Youth in Outpatient Mental Health Settings

A Trial of Neurofeedback as an Adjunctive Treatment for Youth in Outpatient Mental Health Settings

The purpose of this study is to test the feasibility and effectiveness of a neurofeedback intervention conducted as an adjunctive behavioral health treatment to reduce trauma and affective symptoms in trauma-exposed youth.

Inclusion Criteria:

(children)

• caregiver-reported exposure to two or more ACE types on the ACE-Q-Child measure.
• ages of 6-12 years old
• receiving or eligible to receive trauma-focused cognitive behavior therapy or another type of trauma-focused therapy, as determined by their primary therapist, designated as the TAU condition
• speaks and reads English

(caregivers)

• own an iPhone, iPad, smartphone, or tablet that is equipped with Bluetooth and uses an Apple or Android operating system that is compatible with the MUSE Calm app and accompanying MUSE wearable neurofeedback device
• speaks and read English

Exclusion Criteria:

Child-caregiver dyads will be excluded if

• the child falls outside of the required age range,
• has a documented history of epilepsy
• is currently considered to be at high risk for suicide attempt
• is currently experiencing psychosis